CD2 Immunobiology

  • Front Immunol. 2020 Jun 9:11:1090. doi: 10.3389/fimmu.2020.01090.
Christian Binder  1  2 Filip Cvetkovski  2 Felix Sellberg  1  2 Stefan Berg  2 Horacio Paternina Visbal  1  2 David H Sachs  2  3 Erik Berglund  2  4 David Berglund  1  2
Affiliations
  • 1. Department of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala University, Uppsala, Sweden.
  • 2. Research and Development, ITB-Med AB, Stockholm, Sweden.
  • 3. Department of Medicine, Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, United States.
  • 4. Division of Transplantation Surgery, CLINTEC, Karolinska Institute, and Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden.
Abstract

The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several Other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation.

Keywords
Alefacept; CD2; CD58; LFA-3 (lymphocyte functional antigen-3); T cell activation; costimulation; costimulation blockade; siplizumab.
Products